Clearance Summary
XTEND-ST NUCLEUS REMOVAL SYSTEM, MODEL 9004 received FDA 510(k) clearance under submission number K090303, sponsored by Corespine Technologies, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2009-04-30.
- Submission: K090303
- Applicant / Sponsor: Corespine Technologies, LLC
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.1100
- Decision date: 2009-04-30
Classification & Regulation
This clearance is catalogued under FDA product code HRX and 21 CFR 888.1100, within the Orthopedic review panel as a Class II device.